Literature DB >> 564681

Description of a technique for the analysis of antineuraminidase antibodies oriented to H2N2 and H3N2 influenza virus strains.

J Drescher.   

Abstract

A method for the analysis of mixtures of antineuraminidase (AN) antibodies oriented to antigenically different neuraminidases of H2N2 and H3N2 influenza virus strains is described. The method is based on the finding that the different classes of AN antibodies give different titer ratios when reacting with the recombinants A/Bel/42 (H0)-A/Sing/1/57 (N2) and A/equine/Prague/1/56 (Heg1)-A/Hong Kong/1/68 (N2) and a mixture of both recombinants. These titer ratios are determined under the experimental conditions of the photometric ACU (antibody concentration unit) method for a series of reference sera and test sera. By mathematical treatment of these data an exact analysis of AN antibodies of test sera is achieved. This paper gives a detailed description of the conduct of the test and summarizes the results of experiments to designed to assess the accuracy of analysis.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 564681     DOI: 10.1007/bf01317288

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  13 in total

1.  Kinetics of reactions of antihemagglutinin and antineuraminidase antibodies with H2N2 and H3N2 influenza virus strains and description of a modification of the photometric ACU method for titration of antineuraminidase antibodies.

Authors:  J Drescher; U Desselberger
Journal:  Arch Virol       Date:  1976       Impact factor: 2.574

2.  Induction of partial immunity to influenza by a neuraminidase-specific vaccine.

Authors:  R B Couch; J A Kasel; J L Gerin; J L Schulman; E D Kilbourne
Journal:  J Infect Dis       Date:  1974-04       Impact factor: 5.226

3.  Influenzavirus neuraminidase and neuraminidase-inhibition test procedures.

Authors:  M Aymard-Henry; M T Coleman; W R Dowdle; W G Laver; G C Schild; R G Webster
Journal:  Bull World Health Organ       Date:  1973       Impact factor: 9.408

4.  The significance of influenza virus neuraminidase in immunity.

Authors:  R Rott; H Becht; M Orlich
Journal:  J Gen Virol       Date:  1974-01       Impact factor: 3.891

5.  Association of serum anti-neuraminidase antibody with resistance to influenza in man.

Authors:  B R Murphy; J A Kasel; R M Chanock
Journal:  N Engl J Med       Date:  1972-06-22       Impact factor: 91.245

6.  Antibody response to influenza virus enzyme in man.

Authors:  F M Davenport; E Minuse; A V Hennessy
Journal:  Arch Environ Health       Date:  1970-09

7.  Neuraminidase and resistance to vaccination with live influenza A2 Hong Kong vaccines.

Authors:  A N Slepushkin; G C Schild; A S Beare; S Chinn; D A Tyrrell
Journal:  J Hyg (Lond)       Date:  1971-12

8.  Effect of influenza anti-neuraminidase antibody on virus neutralization.

Authors:  J A Kasel; R B Couch; J L Gerin; J L Schulman
Journal:  Infect Immun       Date:  1973-07       Impact factor: 3.441

9.  The role of antineuraminidase antibody in immunity to influenza virus infection.

Authors:  J L Schulman
Journal:  Bull World Health Organ       Date:  1969       Impact factor: 9.408

10.  Persistent antigenic variation of influenza A viruses after incomplete neutralization in ovo with heterologous immune serum.

Authors:  I ARCHETTI; F L HORSFALL
Journal:  J Exp Med       Date:  1950-11-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.